tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Annovis Bio price target lowered to $10 from $12 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Annovis Bio (ANVS) to $10 from $12 and keeps a Buy rating on the shares. The firm says the company’s buntanetap Alzheimer’s disease pivotal trial remains in progress. It cites a lengthier time to potential approval for the target cut.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1